Evidence map›Paper›PMID 25501794›Full record

ReviewMarine drugs2014

Marine Pseudovibrio sp. as a novel source of antimicrobials.

Susan P Crowley, Fergal O'Gara, Orla O'Sullivan, Paul D Cotter, Alan D W Dobson

Open access · goldAbstract readReview
In one paragraph

Review in Marine drugs, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Susan P CrowleyTeagasc, Moorepark Food Research Centre, Fermoy Co. Cork, Ireland. susan.crowley@teagasc.ie.
Fergal O'GaraSchool of Microbiology, University College Cork, Western Road, Cork, Ireland. f.ogara@ucc.ie.
Orla O'SullivanTeagasc, Moorepark Food Research Centre, Fermoy Co. Cork, Ireland. orla.osullivan@teagasc.ie.
Paul D CotterTeagasc, Moorepark Food Research Centre, Fermoy Co. Cork, Ireland. paul.cotter@teagasc.ie.
Alan D W DobsonSchool of Microbiology, University College Cork, Western Road, Cork, Ireland. a.dobson@ucc.ie.
Teagasc - The Irish Agriculture and Food Development Authority · IEUniversity College Cork · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance among pathogenic microorganisms is becoming ever more common. Unfortunately, the development of new antibiotics which may combat resistance has decreased. Recently, however the oceans and the marine animals that reside there have received increased attention as a potential source for natural product discovery. Many marine eukaryotes interact and form close associations with microorganisms that inhabit their surfaces, many of which can inhibit the attachment, growth or survival of competitor species. It is the bioactive compounds responsible for the inhibition that is of interest to researchers on the hunt for novel bioactives. The genus Pseudovibrio has been repeatedly identified from the bacterial communities isolated from marine surfaces. In addition, antimicrobial activity assays have demonstrated significant antimicrobial producing capabilities throughout the genus. This review will describe the potency, spectrum and possible novelty of the compounds produced by these bacteria, while highlighting the capacity for this genus to produce natural antimicrobial compounds which could be employed to control undesirable bacteria in the healthcare and food production sectors.

Indexed as

AnimalsAnti-Bacterial AgentsAnti-Infective AgentsBacteriaBiological ProductsMarine BiologyRhodobacteraceaeAnti-Bacterial AgentsAnti-Infective AgentsBiological Products

Identifiers

PMID25501794
PMCPMC4278209
OpenAlexW1968792295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.